bioRxivCell BiologyPreprint
SARS-CoV-2 shifts transcription of host gene to increase Spike acylation and boost infectivity
F. S. Mesquita, L. Abrami, L. Bracq, N. Panyain, V. Mercier, B. Kunz, A. Chuat, J. Carlevaro-Fita, D. Trono, F. G. van der Goot
Abstract
SARS-CoV-2 infection requires Spike protein mediating fusion between the viral and cellular membranes. The fusogenic activity of Spike requires its post-translational lipid modification by host S-acyltransferases, predominantly ZDHHC20. Previous observations indicate that SARS-CoV-2 infection augments the S-acylation of Spike when compared to transfection. Here, we find that SARS-CoV-2 infection triggers a change in the transcriptional start site of the zddhc20 gene, both in cells and in an in vivo infection model, resulting in a 67-amino-acid-long N-terminally extended protein with 37-times higher Spike acylating activity, leading to enhanced viral infectivity. Furthermore, we observed the same induced transcriptional change in response to other challenges, such as chemically induced colitis, indicating that SARS-CoV-2 hijacks an existing cell damage response pathway to generate more infectious viruses.
- organism: human
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- S-acylation controls SARS-Cov-2 membrane lipid organization and enhances infectivity
F. S. Mesquita, L. Abrami, … F. G. van der Goot·bioRxiv·Mar 14, 2021
- Inhibition of SARS-CoV-2 spike protein palmitoylation reduces virus infectivity
Ahmed Ramadan, Karthick Mayilsamy, … Arunava Roy·bioRxiv·Oct 7, 2021
- Transcription regulation of SARS-CoV-2 receptor ACE2 by Sp1: a potential therapeutic target
- Fatty Acid Synthase inhibitor TVB-3166 prevents S-acylation of the Spike protein of human coronaviruses.
K. Mekhail, M. Lee, … G. D. Fairn·Journal of Lipid ResearchPeer-reviewed·Sep 1, 2022
- SARS-CoV-2 Nsp2 reprograms host immunity to drive pathogenic inflammation
Émile Lacasse, Isabelle Dubuc, … Louis Flamand·bioRxiv·May 7, 2026
- BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2
A. J. Samelson, Q. D. Tran, … M. Kampmann·bioRxiv·Jan 19, 2021